This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: François Maltais: Innovator in Pharmaceutical Inventions
Introduction
François Maltais is a notable inventor based in Tewksbury, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit specific pathways related to various diseases.
Latest Patents
Maltais holds a patent for "Inhibitors of C-MET and uses thereof." This invention relates to compounds that are useful as inhibitors of PI3K, specifically targeting PI3Kγ. The patent also includes pharmaceutically acceptable compositions that comprise these compounds and outlines methods for using these compositions in the treatment of various diseases, conditions, or disorders. He has 1 patent to his name.
Career Highlights
François Maltais is currently employed at Vertex Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has allowed him to contribute to advancements that may improve patient outcomes.
Collaborations
Throughout his career, Maltais has collaborated with notable colleagues, including Tiansheng Wang and Jeremy Green. These collaborations have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.
Conclusion
François Maltais is a dedicated inventor whose work in pharmaceutical inventions has the potential to make a significant impact on healthcare. His contributions, particularly in the area of C-MET inhibitors, highlight the importance of innovation in treating complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
